Psychedelic medicine pioneer exits MDMA biotech after regulatory blow
Stay informed with free updates Simply sign up to the Pharmaceuticals sector myFT Digest — delivered directly to your inbox. Psychedelic medicine pioneer Rick Doblin has left the board of….